ReviewRespiration; international review of thoracic diseases2025
Palliative Care for Patients with Severe Chronic Lung Diseases: A Swiss Position Paper.
Review in Respiration; international review of thoracic diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Nurse-led tele-palliative care for symptom management and family support: A hybrid umbrella review of reviews and primary studies.Palliative & supportive care · 2026Pooled it
- Oxygen therapy in interstitial lung disease - navigating benefit and burden.Current opinion in pulmonary medicine · 2026Review
- Visibility of breathlessness in fibrotic interstitial lung disease: perceptions of international healthcare professionals.ERJ open research · 2026Article
- The Current Status, Challenges, and Optimization Strategies for Self-Management in Patients with COPD: A Review.International journal of chronic obstructive pulmonary disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
<p>Background: Severe chronic lung diseases are frequently associated with a high symptom burden, dependence on caregivers, poor quality of life, and a high risk of early mortality. Medical, psychological, and social situations can become increasingly complex despite established disease-modifying treatment. In patients with lung cancer, palliative care (PC) is well established; however, PC is typically underused in chronic lung diseases including chronic obstructive pulmonary disease, interstitial lung disease, and pulmonary hypertension. With this position paper, the multidisciplinary and interprofessional expert group aims to guide healthcare professionals on how to assess and address PC needs and when to refer patients for specialized PC. Furthermore, the objectives include to increase awareness and to encourage interprofessional education and research on PC in patients with chronic lung diseases. Summary: PC is a holistic, multidisciplinary, person-centered approach to control symptoms, improve quality of life in patients with severe chronic respiratory diseases, and support their caregivers. PC and symptom-oriented treatment should be delivered early alongside with disease-modifying treatment and adapted to individual values and needs of patients and caregivers. General PC can be provided by nonspecialists whereas a specialized PC team is needed when symptoms become challenging to treat and care situations become increasingly complex. Key Messages: Patients with severe chronic lung diseases and their caregivers benefit tremendously from PC, which ranges from simple symptom control to complex interventions delivered by multidisciplinary and interprofessional teams. There is still a clear need to improve availability, awareness, education, and research on PC for patients with severe chronic lung diseases. </p>.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.